Law360 (March 1, 2018, 7:00 PM EST) -- The Patent Trial and Appeal Board on Wednesday upheld a patent covering a tool used to treat an eye disorder, finding accused infringer MiBo Medical Group hadn't shown the invention was obvious.
The PTAB, in a final decision, ruled MiBo failed during inter partes review to prove that any of the challenged claims in Blephex LLC's patent were invalid. Lake Worth, Florida-based Blephex sued its rival in early 2016 and accused it of infringement.
Attorneys for both sides could not immediately be reached for comment.
Blephex's patented device is used to treat people with blepharitis, an infection of the eyelid....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!